Jazz Pharmaceuticals
JAZZ
#2270
Rank
A$10.16 B
Marketcap
$164.66
Share price
0.91%
Change (1 day)
-20.09%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): A$0.44 B

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings (TTM) are A$0.44 B. In 2023 the company made an earning of A$0.44 B an increase over its 2022 earnings that were of -A$0.56 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.44 B0.42%
2023 A$0.44 B-179.92%
2022 -A$0.56 B230.37%
2021 -A$0.17 B-141.02%
2020 A$0.41 B-39.45%
2019 A$0.68 B-14.2%
2018 A$0.79 B20.03%
2017 A$0.66 B-17.15%
2016 A$0.79 B22.14%
2015 A$0.65 B187.64%
2014 A$0.22 B-50.79%
2013 A$0.46 B73.63%
2012 A$0.26 B41.69%
2011 A$0.18 B116.61%
2010 A$86.67 M262.77%
2009 A$23.89 M-111.33%
2008 -A$0.22 B1.31%
2007 -A$0.21 B77.8%
2006 -A$0.12 B36.59%
2005 -A$85.71 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$3.59 B-904.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$3.14 B 605.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.34 B 3,565.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$1.24 B 178.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel